J. Greiner

J. Schlom, D. Zaharoff, J. Greiner, 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms.

J. Schlom, J. Greiner, H. Zeytin, 2005, Vaccine.

A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro‐intestinal epithelium

J. Schlom, J. Simpson, R. Muraro, 1989, International journal of cancer.

Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.

S. Pestka, P. Fisher, J. Schlom, 1986, Cancer research.

Development of a metastatic human colon cancer xenograft model in the nude mouse

J. Greiner, D. Colcher, J. Lundy, 1986, Journal of surgical oncology.

Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.

J. Schlom, J. Kantor, J. Greiner, 1996, Cancer research.

The Use of T Cell Costimulation to Enhance the Immunogenicity of Tumors

J. Schlom, R. Madan, J. Gulley, 2014 .

Recombinant TRICOM-based Therapeutic Cancer Vaccines

J. Schlom, R. Madan, J. Gulley, 2013 .

Chapter 20 – Recombinant TRICOM-based Therapeutic Cancer Vaccines: Lessons Learned

J. Schlom, R. Madan, J. Gulley, 2013 .

Vaccinationwith a Recombinant Saccharomyces cerevisiae Expressing aTumorAntigen Breaks ImmuneTolerance and ElicitsTherapeutic Antitumor Responses

M. Bernstein, J. Schlom, Zhimin Guo, 2008 .

Recombinant human leukocyte interferon induces alterations in the antigen phenotype of human breast carcinoma cells.

J. Greiner, 1986, Anticancer research.

Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.

J. Schlom, M. Anver, J. Greiner, 2002, Cancer research.

Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells.

J. Schlom, J. Greiner, C. D. Ullmann, 1992, Journal of immunotherapy.

TAG-72 expression and its role in the biological evaluation of human colorectal cancer.

F. Guadagni, S. Carlini, J. Schlom, 1996, Anticancer research.

Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody

J. Schlom, J. Greiner, J. Fallon, 2017, Oncotarget.

Improved experimental radioimmunotherapy of colon xenografts by combining131I-CC49 and Interferon-γ

F. Guadagni, J. Schlom, M. Roselli, 1994 .

Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.

S. Steinberg, J. Schlom, J. Greiner, 1993, Cancer research.

Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.

S. Pestka, P. Hand, J. Schlom, 1988, Journal of interferon research.

Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.

J. Carrasquillo, D. Milenic, J. Greiner, 1995, Cancer research.

Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.

J. Schlom, J. Greiner, K. Tsang, 1995, Immunology letters.

Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.

J. Schlom, K. Irvine, S. Abrams, 1992, Cancer research.

Monoclonal antibodies to breast cancer‐associated antigens as potential reagents in the management of breast cancer

S. Pestka, P. Fisher, P. Hand, 1984, Cancer.

Immunization with a Syngeneic Tumor Infected with Recombinant Vaccinia Virus Expressing Granulocyte‐Macrophage Colony‐Stimulating Factor (GM‐CSF) Induces Tumor Regression and Long‐Lasting Systemic Immunity

J. Schlom, S. Abrams, J. Kantor, 1997, Journal of immunotherapy.

Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.

P. Fisher, J. Schlom, M. Gutiérrez, 1989, Anticancer research.

Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells.

S. Pestka, J. Schlom, S. Kashmiri, 1988, Cancer research.

Radioimmunoassay for detection of changes in cell surface tumor antigen expression induced by interferon.

J. Greiner, D. Wunderlich, D. Colcher, 1986, Methods in enzymology.

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

J. Murray, D. Podoloff, J. Schlom, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma.

F. Guadagni, K. D. Hardman, J. Schlom, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Tumor markers as targets for selective diagnostic and therapeutic procedures.

F. Guadagni, J. Schlom, P. Ferroni, 1996, Anticancer research.

Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation

A. Vecchione, F. Guadagni, J. Schlom, 1997, International journal of cancer.

Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer

R. Adam, P. Black, B. Inman, 2018, Bladder cancer.

Therapeutic cancer vaccines.

J. Schlom, R. Madan, J. Gulley, 2014, Advances in cancer research.

TWO Therapeutic Cancer Vaccines

J. Schlom, R. Madan, J. Gulley, 2014 .

Improved Tumor Radioimmunodetection Using a Single-Chain Fv and γ-Interferon: Potential Clinical Applications for Radioimmunoguided Surgery and γ Scanning

Jorge A. Carrasquillo, J. Schlom, J. Carrasquillo, 1995 .

Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12

J. Schlom, J. Greiner, Z. Su, 2019, Journal of Immunotherapy for Cancer.

Physical Activity and Cancer Prevention

S. Perkins, J. Greiner, C. Rogers, 2008, Sports medicine.

Vaccination with a Recombinant Saccharomyces cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses

M. Bernstein, J. Schlom, Zhimin Guo, 2008, Clinical Cancer Research.

Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.

J. Greiner, K. Hance, H. Zeytin, 2005, Mutation research.

Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells.

F. Guadagni, J. Schlom, E. Borden, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

J. Greiner, C. Rogers, K. Hance, 2007, Frontiers in bioscience : a journal and virtual library.

Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression

S. Pestka, P. Fisher, M. Tobi, 1985, International journal of cancer.

Mice Expressing the Human Carcinoembryonic Antigen

J. Greiner, 2002 .

Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.

J. Schlom, J. Greiner, J. Schmitz, 2002, Cancer research.

Combination of a Poxvirus-Based Vaccine with a Cyclooxygenase-2 Inhibitor (Celecoxib) Elicits Antitumor Immunity and Long-Term Survival in CEA.Tg/MIN Mice

J. Schlom, J. Greiner, C. Rogers, 2004, Cancer Research.

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele

J. Schlom, S. Rabizadeh, P. Soon-Shiong, 2016, Oncotarget.

Carcinoembryonic Antigen as a Vaccine Target

J. Schlom, J. Greiner, K. Tsang, 2001 .

Cancer vaccine development.

J. Schlom, S. Abrams, J. Kantor, 1998, Expert opinion on investigational drugs.

Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor

J. Schlom, H. Sabzevari, J. Greiner, 2016, Cancer Immunology Research.

Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentation.

A. Vecchione, F. Guadagni, E. Brunetti, 1998, Seminars in surgical oncology.

Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.

F. Guadagni, R. Mariani-Costantini, J. Schlom, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.

F. Guadagni, J. Schlom, C. Van Waes, 2002, Cancer research.

NHS-IL12, a Tumor-Targeting Immunocytokine

J. Schlom, J. Greiner, Y. M. Morillon, 2021, ImmunoTargets and therapy.

Immunity and Long-Term Survival in CEA . Tg / MIN Mice Cyclooxygenase-2 Inhibitor ( Celecoxib ) Elicits Antitumor Combination of a Poxvirus-Based Vaccine with a

J. Schlom, J. Greiner, C. Rogers, 2004 .

Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis

J. Schlom, J. Greiner, K. Tsang, 2014, Cancer Immunology, Immunotherapy.

Measurement of the effect of interferons on the proliferative capacity and cloning efficiency of normal and leukemic human myeloid progenitor cells in culture.

P. Fisher, J. Schlom, S. Grant, 1986, Methods in enzymology.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

F Graziano, S. Steinberg, F. Guadagni, 2001, Cancer research.

Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review).

F. Guadagni, J. Schlom, M. Roselli, 1993, In vivo.

Effect of recombinant α-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer : A phase II trial

J. Murray, D. Podoloff, J. Schlom, 1997 .

Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.

S. Pestka, P. Fisher, F. Guadagni, 1990, Cancer treatment and research.

Modulation of antigen expression in human tumor cell populations.

J. Greiner, 1986, Cancer investigation.

Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice.

D. Berrigan, J. Schlom, D. Zaharoff, 2008, The Journal of nutrition.

A human T cell line engineered to secrete chimeric monoclonal antibody.

J. Schlom, B. Calvo, S. Kashmiri, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

P. Pinto, J. Schlom, D. Zaharoff, 2009, Cancer research.

Comparison of the interferon-gamma-mediated regulation of tumor-associated antigens expressed by human gastric carcinoma cells.

J. Schlom, M. Ogawa, J. Greiner, 1993, In vivo.

Strategies in the development of recombinant vaccines for colon cancer.

J. Schlom, S. Abrams, J. Kantor, 1999, Seminars in oncology.

Preclinical and Clinical Use of Chitosan and Derivatives for Biopharmaceuticals: From Preclinical Research to the Bedside

D. Zaharoff, J. Greiner, M. Heffernan, 2012 .

Synergistic Effects of IL-6 and IFN-γ on Carcinoembryonic Antigen (CEA) and HLA Expression by Human Colorectal Carcinoma Cells: Role for Endogenous IFN-β

J. Schlom, M. Salgaller, J. Greiner, 1995 .

Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.

J. Schlom, M. Salgaller, J. Greiner, 1995, Cytokine.

Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas

F. Guadagni, J. Schlom, E. Borden, 1991, Journal of surgical oncology. Supplement.

Cytokine-Based Modalities to Enhance Monoclonal-Antibody-Mediated Tumor Cell Killing

F. Guadagni, J. Schlom, J. Greiner, 2018 .

Therapeutic cancer vaccines.

J. Schlom, R. Madan, J. Gulley, 2014, Advances in cancer research.

Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment.

J. Murray, D. Podoloff, J. Schlom, 1995, Cancer research.

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.

J. Verweij, J. Schellens, G. Schwartz, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor

J. Schlom, H. Sabzevari, J. Greiner, 2016, Cancer Immunology Research.

Different Human Colorectal Tumor Cells by Interferon-Regulation of Carcinoembryonic Antigen Expression in Updated Version

F. Guadagni, J. Schlom, P. Robbins, 2006 .

Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.

J. Schlom, D. Zaharoff, J. Greiner, 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Molecular Cloning and Characterization of the Complementary DNA of an Mr 110,000 Antigen Expressed by Human Gastric Carcinoma Cells and Upregulated by γ-Interferon

J. Schlom, M. Ogawa, J. Greiner, 1994 .

Vaccination with a Recombinant Saccharomyces cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses

M. Bernstein, J. Schlom, Zhimin Guo, 2008, Clinical Cancer Research.

Vaccinationwith a Recombinant Saccharomyces cerevisiae Expressing aTumorAntigen Breaks ImmuneTolerance and ElicitsTherapeutic Antitumor Responses

M. Bernstein, J. Schlom, Zhimin Guo, 2008 .